Notice: file_put_contents(): Write of 1422 bytes failed with errno=28 No space left on device in /var/www/tg-me/post.php on line 50

Warning: file_put_contents(): Only 8192 of 9614 bytes written, possibly out of free disk space in /var/www/tg-me/post.php on line 50
Readhub | Telegram Webview: readhub_cn/250195 -
Telegram Group & Telegram Channel



tg-me.com/readhub_cn/250195
Create:
Last Update:

君实生物:特瑞普利单抗新适应症上市申请获批

君实生物公告,特瑞普利单抗联合贝伐珠单抗用于肝细胞癌一线治疗的新适应症获批,这是其在中国的第11项适应症。

媒体报道
君实生物:特瑞普利单抗联合贝伐珠单抗一线治疗晚期肝细胞癌的新适应症上市申请获得批准 财联社
君实生物:特瑞普利单抗新适应症上市申请获批 第一财经
君实生物特瑞普利单抗获批第11项适应症 | 会员动态 医药魔方

事件追踪
2025-01-06 君实生物:特瑞普利单抗二线及以上治疗黑色素瘤获常规批准
2024-11-17 君实生物:特瑞普利单抗获英国药品和保健品管理局批准上市
2024-10-11 君实生物降血脂药物昂戈瑞西单抗获批
2024-06-26 君实生物现涨近4% 特瑞普利单抗三阴性乳腺癌适应症在中国获批
2024-06-12 君实生物「特瑞普利单抗」获批第9项适应症,一线治疗小细胞肺癌
2023-12-01 君实生物:特瑞普利单抗上市许可申请获得澳大利亚药品管理局受理
2023-10-30 首款国产PD-1美国获批,君实生物股价有望触底反弹
2023-10-30 君实生物:鼻咽癌治疗的特瑞普利单抗获得FDA批准上市

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/250195

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

Telegram hopes to raise $1bn with a convertible bond private placement

The super secure UAE-based Telegram messenger service, developed by Russian-born software icon Pavel Durov, is looking to raise $1bn through a bond placement to a limited number of investors from Russia, Europe, Asia and the Middle East, the Kommersant daily reported citing unnamed sources on February 18, 2021.The issue reportedly comprises exchange bonds that could be converted into equity in the messaging service that is currently 100% owned by Durov and his brother Nikolai.Kommersant reports that the price of the conversion would be at a 10% discount to a potential IPO should it happen within five years.The minimum bond placement is said to be set at $50mn, but could be lowered to $10mn. Five-year bonds could carry an annual coupon of 7-8%.

However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.

Readhub from br


Telegram Readhub
FROM USA